TECAN GROUP AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 305.2 CHF | +0.99% |
|
+1.33% | -11.12% |
| Jun. 24 | Tecan Appoints Mukta Acharya as Head of the Life Sciences Business Division, Effective from August 1, 2024 | CI |
| Apr. 18 | Tecan Group Approves Dividend, Payable on April 24, 2024 | CI |
| Sales 2024 * | 1.08B 1.2B | Sales 2025 * | 1.16B 1.29B | Capitalization | 3.91B 4.33B |
|---|---|---|---|---|---|
| Net income 2024 * | 125M 138M | Net income 2025 * | 145M 160M | EV / Sales 2024 * | 3.45 x |
| Net cash position 2024 * | 175M 194M | Net cash position 2025 * | 279M 309M | EV / Sales 2025 * | 3.12 x |
| P/E ratio 2024 * |
31.4
x | P/E ratio 2025 * |
26.8
x | Employees | 3,444 |
| Yield 2024 * |
0.99% | Yield 2025 * |
1.04% | Free-Float | 99.75% |
More Fundamentals
* Assessed data
More news
Latest transcript on Tecan Group AG
More recommendations
More press releases
More news
| 1 day | +0.99% | ||
| 1 week | -1.86% | ||
| Current month | +1.46% | ||
| 1 month | -4.45% | ||
| 3 months | -18.35% | ||
| 6 months | -11.12% | ||
| Current year | -11.12% |
1 week
294.20
307.60
1 month
294.20331.00
Current year
294.20392.00
1 year
251.00392.00
3 years
251.00602.00
5 years
221.20602.00
10 years
89.05602.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 13-08-08 | |
Tania Micki
DFI | Director of Finance/CFO | 52 | 20-02-29 |
Ulrich Kanter
COO | Chief Operating Officer | 61 | 14-07-13 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Daniel Marshak
BRD | Director/Board Member | 67 | 18-04-16 |
| Chairman | 68 | 18-04-16 | |
Karen Hübscher
BRD | Director/Board Member | 61 | 12-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.54% | 144 M€ | -2.20% | ||
| 0.08% | 775 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-02 | 305.2 | +0.99% | 41,783 |
| 24-07-01 | 302.2 | +0.47% | 22,306 |
| 24-06-28 | 300.8 | -0.86% | 32,976 |
| 24-06-27 | 303.4 | +0.26% | 27,632 |
| 24-06-26 | 302.6 | +0.46% | 33,770 |
Delayed Quote Swiss Exchange, July 02, 2024 at 11:30 am EDT
More quotes
Tecan Group AG is a Switzerland-based company engaged in the development, production and distribution of advanced automation and detection solutions for the life science laboratories. Its product portfolio is diversified into several product groups. The Liquid Handling & Robotics group encompasses laboratory technologies for safety, among others. The Reader & Washer product group covers micro plate instruments. The Microarray Products group includes microarray scanner and automated hybridization station. The HP D300 Digital Dispenser and Sample Management product groups cover systems for automated management of sample libraries. The Components group covers the supply services of products for laboratory automation instruments. The OEM (original equipment manufacturing) product group covers platform-based systems, systems from scratch and Cavro OEM Components. The Company also offers packaged software and consumables through Software and Consumables product groups, respectively.
Sector
Office Equipment
Calendar
2024-08-12
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
305.2
CHF
Average target price
396.6
CHF
Spread / Average Target
+29.94%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -11.12% | 4.29B | |
| +2.31% | 3.19B | |
| +16.74% | 2.27B | |
| +8.91% | 1.03B | |
| +8.93% | 950M | |
| -41.40% | 925M | |
| -59.03% | 667M | |
| -35.65% | 636M | |
| -29.46% | 631M | |
| -36.83% | 565M |
- Stock Market
- Equities
- TECN Stock
